Sign inJoin waitlistJoin the waitlist

Julio Chavez

Physician · Mayo Clinic Florida Hospital

Credentials: · · · ·

History

Mayo Clinic Florida Hospital
2026–Present

Medical Oncology
2003–2005
Internal Medicine
2000–2003
Doctor of Medicine
1996–2000

Research

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine · 2017 · 4,914 citations
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
The Lancet Oncology · 2019 · 1,921 citations
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Journal of Clinical Oncology · 2020 · 691 citations

FL
Frederick Locke
52 papers
BS
Bijal Shah
48 papers
MJ
Michael Jain
41 papers
Mohamed Dabaja
37 papers
Javier Pinilla-Ibarz
30 papers
TN
Taiga Nishihori
30 papers
AL
Aleksandr Lazaryan
26 papers
FK
Farhad Khimani
24 papers
LS
Lubomir Sokol
22 papers
Jose Sandoval-Sus
18 papers
Marco Davila
18 papers
Ernesto Ayala
17 papers

Clinical trials

Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
Principal investigator · Terminated · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2019–2023
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
2016–2026
Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)
Sub-investigator · Recruiting · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2025–2028
Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym
Sub-investigator · Recruiting · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2025–2028